The Real-Time PCR (qPCR) Market to Keep Up the Digitized Technology Momentum

The Real-Time PCR (qPCR) Market is expected to grow on an unabashed note in the next decade. With a worldwide shortage of healthcare staff, the healthcare IT solutions comprising web-based staffing platforms are doing the rounds. The future scenario won't be any different. These platforms would show the gaps, i.e. actual dearth of healthcare personnel like nurse's doctors, technicians, lab workers, and clinicians, which would help the entire healthcare vertical to take measures to bridge the gap between demand and supply. This would be an important development in the healthcare industry going forward.
Surging real-time PCR (qPCR) adoption for the diagnosis and estimation of disease-causing microbes due to increasing product availability is expected to drive the growth of the real-time PCR (qPCR) market. Also, there is high awareness among the patient population about new diagnosis and availability of advanced PCR products. For instance, in April, 2020, Takara Bio suggested keys to sustenance clinicians and researchers studying the novel coronavirus, such as real-time PCR kits that can be used with recognized primers for complex detection of COVID-19. This is of great importance with the wide spread of the coronavirus that is taking place across the globe, which, in turn, is expected to boost the demand for real-time PCR (qPCR).

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/31513

Moreover, higher purchasing power and initiation of automated real-time PCR instruments are major factors aiding the growth of the real-time PCR (qPCR) market. Increasing collaborations, R&D investments toward developing kits, reagents, consumables, etc., as effective real-time products, along with a refined chain of local distribution networks are expected to boost market growth.

The global real-time PCR (qPCR) market was valued at US$ 2.8 Bn in 2019, and is expected to exhibit a CAGR of more than 8% during the forecast period (2020-2030).

Company Profiles:

Thermofischer Scientific Inc.
Bio-Rad Laboratories Inc.
Agilent Technologies, Inc.
BIOTECON Diagnostics
Sigma-Aldrich Co. LLC.
Takara Bio Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
QIAGEN N.V.

Get A Customized Scope To Match Your Need Ask An Expert - sales@persistencemarketresearch.com

Key Takeaways of Real-Time PCR (qPCR) Market Study

Based on product, due to superior product efficiency, real-time PCR (qPCR) reagents and assays together generated over 42% market value share in 2019.
Various product launches by key players along with technological advancements are expected to dominate the demand for real-time PCR (qPCR). For instance, in 2019, Bio-Rad Laboratories, Inc. announced the launch of real-time PCR (qPCR) kits that are named Aspergillus iQ-Check RT-PCR Kits, which are used for the detection of Aspergillus.
In terms of end user, both, academic and research institutes and biopharmaceutical companies hold over 44% of market value share, due to the growing use of real-time PCR (qPCR) techniques in drug development and other research activities.

For critical insights, request for methodology @ https://www.persistencemarketresearch.com/methodology/31513

North America captured over 1/2 real-time PCR (qPCR) market value share, and is expected to be the most lucrative region in the global market during the forecast period. The market in the region is characterized by higher prevalence and diagnosis rates of infectious diseases, and rising awareness regarding advanced real-time PCR (qPCR) devices.
"Increasing adoption of real-time PCR (qPCR) for diagnosis and estimation of disease-causing microbes, along with its cost-effectiveness, and availability of low end products in most of the countries, are some of the factors expected to propel the growth of the global real-time PCR (qPCR) market through 2030," says a PMR analyst.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/31513

Collaboration & Launching of New Products - An Imperative Strategy for Market Players

Market introduction of new real-time PCR (qPCR) products and collaboration with various larger as well as regional market players are some of the major factors responsible for the intense competition among real-time PCR (qPCR) market players. Most companies in the real-time PCR (qPCR) market are small & medium business enterprises, which limits the competition of market players to specific regions.

What else is in the report?

Persistence Market Research offers a unique perspective and actionable insights on the real-time PCR (qPCR) market in its latest study, presenting historical demand assessment of 2015-2019 and projections for 2020-2030, based on product (real-time PCR (qPCR) systems, reagents and assays, real-time PCR (qPCR)), application (clinical, research, forensics, and others,), end user (hospitals, diagnostic laboratories, academic and research institutes, biopharmaceutical companies, contract research organizations, animal health, food & agriculture industries, and others), across seven key regions.

Complete Report Details@ https://www.persistencemarketresearch.com/market-research/real-time-pcr-qpcr-market.asp

Read More Trending "PMR Exclusive Article"-

Cell Culture Media Market@ https://www.persistencemarketresearch.com/market-research/cell-culture-media-market.asp

Whole Slide Imaging Systems Market@https://www.persistencemarketresearch.com/market-research/whole-slide-imaging-systems-market.asp

Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About us-
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on "micros" by Persistence Market Research helps companies overcome their "macro" business challenges.

This release was published on openPR.